Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Descriptive Pharmacoepidemiological Study on the Use of Symbicort Turbuhaler in the Treatment of Asthma in France and Impact of a New Therapeutic Strategy on the Compliance and Control of Asthma

NCT00812357 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00812357
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00812357 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Descriptive Pharmacoepidemiological Study on the Use of Symbicort Turbuhaler in the Treatment of Asthma in France and Impact of a New Therapeutic Strategy on the Compliance and Control of Asthma
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
April 30, 2009
Completion date
August 31, 2011
Enrollment
579 (actual)
Sites
168

Conditions

As the registry lists them; a condition with its own page is linked.

asthma